Category: Patent & Other IP Offices
-
Unified Patent Court injunction in 10x Genomics v. NanoString could be reinstated as EPO Opposition Division upholds patent in ‘slightly amended form’
Context: The Unified Patent Court (UPC) opened its doors on June 1, 2023, and only a few months later, in September 2023, 10x Genomics won a preliminary injunction against rival NanoString in the Munich Local Division (LD). NanoString nearly went out of business as a result of that loss, but apparently found an acquirer. The…
-
Gallium nitride patent wars: China’s Innoscience claims “ultimate victory” in ITC litigation against EPC
The United States Patent & Trademark Office has invalidated the only remaining patent in a United States International Trade Commission dispute initiated by Efficient Power Conversion over gallium nitride patents, handing Innoscience a significant win.
-
‘SEPs are life’ but finite resources, geopolitical circumstances put proposed EU SEP Regulation on ‘timeout’: European Commission’s Kamil Kiljański
Speaking at a SEP conference in Warsaw today, DG GROW IP deputy director Kamil Kiljański emphasized that the European Commission’s decision to withdraw its proposed SEP regulation was only on a “timeout” and that a large factor that contributed to this was a shift in geopolitical circumstances – in particular those in the U.S. and…
-
A ‘breakthrough’ that may have gone ‘too far’: fallout follows ECJ’s cross-border jurisdiction ruling
European patent attorneys have largely welcomed a European Court of Justice decision allowing courts to rule on the infringement of U.S., UK, and other foreign patents (as well as award damages and injunctions). But those in foreign jurisdictions, such as China, are concerned that the ruling could lead to “significant chaos” and that the court…
-
Japan’s Nippon Shinyaku vows to fight on in U.S. drug dispute against Sarepta Therapeutics, despite heavy $115 million blow
The Japanese pharma company initiated the drug patent litigation in 2021, but the case eventually boomeranged and a District of Delaware verdict last week ultimately handed Sarepta the win.
-
Chinese medical device makers settle six-year pulse oximeter litigation in the U.S.
Beijing Choice and Contec settled their patent infringement dispute for US$1 million, and the defendant has agreed not to sell its fingertip oximeters in the U.S. without signing a licensing agreement first.
-
Nokia fends off lawsuit in Eastern District of Texas targeting its network infrastructure: three patents not infringed
Nokia has an active patent licensing program and has to enforce if license agreements cannot be concluded otherwise, but also finds itself on the receiving end of patent assertions.
-
European patent attorneys rejoice: Technical Board of Appeal sees no need to adapt description to more limited claims
A Technical Board of Appeal of the European Patent Office has held that the description of a patent does not have to be adapted to match allowable claims of more limited subject matter.
-
UK government helps SMEs with new SEP Resource Hub: wealth of information rather than heavy-handed intervention
The UK Intellectual Property Office today unveiled a treasure trove (particularly for SMEs) of information on standard-essential patent licensing and enforcement.